NABOTA 200U

Nabota 200U is a botulinum toxin type A injection developed by Daewoong Pharmaceutical, designed for aesthetic and therapeutic purposes. It helps temporarily relax muscles, making it effective for treating wrinkles, particularly in areas such as frown lines, forehead lines, and crow’s feet.

 Nabota is also used in medical treatments to address conditions like cervical dystonia, chronic migraines, and hyperhidrosis.

This product offers several benefits, including rapid onset and long-lasting results, making it comparable to well-known products like Botox. A popular choice among clinics and patients, Nabota 200U ensures precise dosing with its high purity, which contributes to safety and effectiveness over multiple uses. The product is especially known for kicking in within a few days of administration and providing results that last several months, typically 3-4 months depending on the individual and treatment area.

Nabota has expanded its availability to several regions, including North America, Europe, and Asia, and is marketed under the brand name Jeuveau in the U.S. as part of an international licensing agreement with Evolus. This product is favored for both aesthetic applications and clinical therapies due to its consistent performance and safety profile.

For professionals, Nabota offers the convenience of a 200-unit vial, which allows for greater flexibility when treating multiple areas or performing high-dose treatments efficiently. This makes it a practical solution for aesthetic clinics managing diverse patient needs.

If you’re considering Nabota for personal use or clinic stocking, it is essential to consult a licensed healthcare provider to ensure proper administration and avoid potential risks.